Kapak Resmi

Low-dose Oral Thimerosal for the Treatment of Oral Herpes: Clinical Trial Results and Improved Outcome After Post-hoc Analysis

Diğer sürümleri göster (1)

Background Thimerosal (TML) is an organomercury antimicrobial. Low doses (1/250 th of the amount in a typical vaccine dose) may promote an antiviral immune response. Low-dose TML (BTL-TML) was evaluated for safety and efficacy against herpes labialis in two FDA-approved, randomized, double blind, pl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Stephen W. Mamber (Yazar), Thomas Hatch (Yazar), Craig S. Miller (Yazar), John V. Murray (Yazar), Cynthia Strout (Yazar), John McMichael (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: SAGE Publishing, 2022-02-01T00:00:00Z.
Konular:
article
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

Connect to this object online.

3rd Floor Main Library

Detaylı Erişim Bilgileri 3rd Floor Main Library
Yer Numarası: A1234.567
Kopya Bilgisi 1 Kütüphanede

Benzer Materyaller